RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > In Focus: Medicines For Children

In Focus: Medicines For Children

Posted 01 March 2008

Most medicines prescribed for children have not been tested in children. In the US, only 20%-30% of medicines approved by the Food and Drug Administration are labeled for pediatric use.1 In the EU, more than 50% of the medicines used in children may not have been studied in this age group.2


© 2022 Regulatory Affairs Professionals Society.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.